A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus

Summary

The main purpose of this study is to learn more about a new formulation of insulin lispro when given by an insulin pump to participants with type 1 diabetes mellitus. The study will investigate how the body processes the drug and how the drug affects the body. Information about side effects will be collected. The study will last from six to 12 weeks for each participant.

Timeline

Start

2019-12-27

Primary completion

2020-07-14

Completion

2020-07-14

Drugs

Indications